CREMECOMTRSBI Financials
| WY52 Stock | EUR 0.05 0.02 68.75% |
CREMECOMTRSBI |
Understanding current and past CREMECOMTRSBI Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CREMECOMTRSBI's financial statements are interrelated, with each one affecting the others. For example, an increase in CREMECOMTRSBI's assets may result in an increase in income on the income statement.
CREMECOMTRSBI Stock Summary
CREMECOMTRSBI competes with Boston Properties, COUSINS PTIES, and Office Properties. CIM Commercial is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States . CIM Commercial is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. CIM COMM operates under REITOffice classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US1255255846 |
| Business Address | 17950 Preston Road |
| Sector | Real Estate |
| Industry | REIT—Office |
| Benchmark | Dow Jones Industrial |
| Website | www.cimcommercial.com |
| Phone | 972 349 3200 |
| Currency | EUR - Euro |
You should never invest in CREMECOMTRSBI without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CREMECOMTRSBI Stock, because this is throwing your money away. Analyzing the key information contained in CREMECOMTRSBI's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CREMECOMTRSBI Key Financial Ratios
There are many critical financial ratios that CREMECOMTRSBI's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CREMECOMTRSBI DL 001 reports annually and quarterly.| Return On Equity | 0.014 | |||
| Return On Asset | 0.0151 | |||
| Target Price | 13.0 | |||
| Beta | 0.54 | |||
| Last Dividend Paid | 0.33 |
CREMECOMTRSBI Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CREMECOMTRSBI's current stock value. Our valuation model uses many indicators to compare CREMECOMTRSBI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CREMECOMTRSBI competition to find correlations between indicators driving CREMECOMTRSBI's intrinsic value. More Info.CREMECOMTRSBI DL 001 is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about 1.08 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CREMECOMTRSBI's earnings, one of the primary drivers of an investment's value.CREMECOMTRSBI DL 001 Systematic Risk
CREMECOMTRSBI's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CREMECOMTRSBI volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on CREMECOMTRSBI DL 001 correlated with the market. If Beta is less than 0 CREMECOMTRSBI generally moves in the opposite direction as compared to the market. If CREMECOMTRSBI Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CREMECOMTRSBI DL 001 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CREMECOMTRSBI is generally in the same direction as the market. If Beta > 1 CREMECOMTRSBI moves generally in the same direction as, but more than the movement of the benchmark.
CREMECOMTRSBI December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CREMECOMTRSBI help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CREMECOMTRSBI DL 001. We use our internally-developed statistical techniques to arrive at the intrinsic value of CREMECOMTRSBI DL 001 based on widely used predictive technical indicators. In general, we focus on analyzing CREMECOMTRSBI Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CREMECOMTRSBI's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 255.32 | |||
| Value At Risk | (32.84) | |||
| Potential Upside | 17.78 |
Complementary Tools for CREMECOMTRSBI Stock analysis
When running CREMECOMTRSBI's price analysis, check to measure CREMECOMTRSBI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CREMECOMTRSBI is operating at the current time. Most of CREMECOMTRSBI's value examination focuses on studying past and present price action to predict the probability of CREMECOMTRSBI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CREMECOMTRSBI's price. Additionally, you may evaluate how the addition of CREMECOMTRSBI to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |